PH30761A - An infant formulation fortified with bile salt-activated lipase. - Google Patents

An infant formulation fortified with bile salt-activated lipase.

Info

Publication number
PH30761A
PH30761A PH43285A PH43285A PH30761A PH 30761 A PH30761 A PH 30761A PH 43285 A PH43285 A PH 43285A PH 43285 A PH43285 A PH 43285A PH 30761 A PH30761 A PH 30761A
Authority
PH
Philippines
Prior art keywords
bssl
fortified
bile salt
sequence given
activated lipase
Prior art date
Application number
PH43285A
Other languages
English (en)
Inventor
Bjursell Gunner
Blackberg Lars
Olivecrona Thomas
Herell Olle
Carlson Peter
Nilsson Jeanette
Enerback Sven
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of PH30761A publication Critical patent/PH30761A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/596—Mixtures of surface active compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PH43285A 1990-06-01 1991-10-11 An infant formulation fortified with bile salt-activated lipase. PH30761A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9001985A SE9001985D0 (sv) 1990-06-01 1990-06-01 New chemical products

Publications (1)

Publication Number Publication Date
PH30761A true PH30761A (en) 1997-10-17

Family

ID=20379662

Family Applications (1)

Application Number Title Priority Date Filing Date
PH43285A PH30761A (en) 1990-06-01 1991-10-11 An infant formulation fortified with bile salt-activated lipase.

Country Status (44)

Country Link
EP (1) EP0535048B1 (cs)
JP (1) JPH05507201A (cs)
KR (1) KR100212411B1 (cs)
CN (2) CN1075113C (cs)
AP (1) AP207A (cs)
AT (1) ATE151077T1 (cs)
AU (1) AU651979B2 (cs)
BG (1) BG61165B1 (cs)
CA (1) CA2083396C (cs)
CZ (1) CZ287470B6 (cs)
DE (1) DE69125489T2 (cs)
DK (1) DK0535048T3 (cs)
DZ (1) DZ1503A1 (cs)
EG (1) EG19937A (cs)
ES (1) ES2099159T3 (cs)
FI (1) FI114639B (cs)
GR (1) GR3023618T3 (cs)
HK (1) HK62497A (cs)
HR (1) HRP920771B1 (cs)
HU (1) HU215258B (cs)
IE (1) IE911844A1 (cs)
IL (1) IL98273A (cs)
IS (1) IS1751B (cs)
JO (1) JO1694B1 (cs)
LT (1) LT4020B (cs)
LV (1) LV10292B (cs)
MA (1) MA22166A1 (cs)
MY (1) MY111245A (cs)
NO (1) NO322962B1 (cs)
NZ (1) NZ238223A (cs)
PH (1) PH30761A (cs)
PL (1) PL166534B1 (cs)
PT (1) PT97836B (cs)
RO (1) RO114793B1 (cs)
RU (1) RU2140983C1 (cs)
SE (1) SE9001985D0 (cs)
SG (1) SG48078A1 (cs)
SK (1) SK281089B6 (cs)
TN (1) TNSN91041A1 (cs)
TW (1) TW221712B (cs)
UA (1) UA39165C2 (cs)
WO (1) WO1991018923A1 (cs)
YU (1) YU49138B (cs)
ZA (1) ZA913778B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP930935A2 (en) * 1992-06-11 1994-12-31 Astra Ab New dna sequences
SE9300686D0 (sv) 1993-03-01 1993-03-01 Astra Ab Novel polypeptides
IS4130A (is) * 1993-03-01 1994-09-02 Ab Astra Ný fjölpeptíð
FR2754827B1 (fr) * 1996-10-17 1998-12-24 Biocem Lipases pancreatiques et/ou colipases recombinantes et polypeptides dervies produits par les plantes, leurs procedes d'obtention et leurs utilisations
JP2000026311A (ja) * 1998-07-02 2000-01-25 Amano Pharmaceut Co Ltd 胃排出能亢進剤組成物
US20090226904A1 (en) * 2005-12-01 2009-09-10 University Of Bergen Diagnosis and treatment of exocrine pancreatic dysfunction and diabetes
AU2011242461B2 (en) 2010-04-23 2015-10-01 Alexion Pharmaceuticals, Inc. Lysosomal storage disease enzyme
DK2613798T4 (en) 2010-09-09 2018-04-16 Synageva Biopharma Corp USING LYSOSOMAL SUR LIPASE TO TREAT PATIENTS WITHOUT LYSOSOMAL SUR LIPASE
AU2010362575A1 (en) 2010-10-21 2013-04-11 Swedish Orphan Biovitrum Ab (Publ) Method to increase the absorption of unsaturated fatty acids by human infants
EP2629790B1 (en) 2010-10-21 2016-08-24 Swedish Orphan Biovitrum AB (Publ) Method to increase the growth velocity of human infants
AU2018288152A1 (en) * 2017-06-19 2020-01-16 Swedish Orphan Biovitrum Ab (Publ) Fusion protein with half-life extending polypeptide
CN115175995B (zh) 2019-08-30 2025-05-02 雀巢产品有限公司 工程化脂肪酶变体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3107684A (en) * 1983-07-01 1985-02-07 Celltech Limited Proteins, pharmaceutical compositions, genes, vectors, host organisms and processes for their production

Also Published As

Publication number Publication date
HRP920771A2 (en) 1997-04-30
SK281089B6 (sk) 2000-11-07
LTIP1736A (en) 1995-08-25
RO114793B1 (ro) 1999-07-30
NO322962B1 (no) 2006-12-18
RU2140983C1 (ru) 1999-11-10
TW221712B (cs) 1994-03-11
WO1991018923A1 (en) 1991-12-12
YU95191A (sh) 1994-06-10
FI925453A0 (fi) 1992-11-30
HRP920771B1 (en) 1999-10-31
CZ164491A3 (cs) 1999-07-14
LV10292A (lv) 1994-10-20
CZ287470B6 (cs) 2000-12-13
CN1064313A (zh) 1992-09-09
EP0535048B1 (en) 1997-04-02
HU215258B (hu) 1998-11-30
DE69125489D1 (de) 1997-05-07
AU651979B2 (en) 1994-08-11
CN1075113C (zh) 2001-11-21
BG61165B1 (bg) 1997-01-31
PT97836A (pt) 1992-02-28
HU9203774D0 (en) 1993-03-29
HK62497A (en) 1997-05-16
ATE151077T1 (de) 1997-04-15
BG97123A (bg) 1993-12-24
HUT63184A (en) 1993-07-28
GR3023618T3 (en) 1997-08-29
EG19937A (en) 2000-12-31
CA2083396A1 (en) 1991-12-02
PL166534B1 (pl) 1995-05-31
NO924528D0 (no) 1992-11-24
NZ238223A (en) 1993-05-26
FI925453L (fi) 1992-11-30
SK164491A3 (en) 1995-07-11
AP9100270A0 (en) 1991-07-31
MY111245A (en) 1999-10-30
MA22166A1 (fr) 1991-12-31
SG48078A1 (en) 1998-04-17
AU7964591A (en) 1991-12-31
CA2083396C (en) 2006-09-19
LT4020B (en) 1996-08-26
TNSN91041A1 (fr) 1992-10-25
JPH05507201A (ja) 1993-10-21
DK0535048T3 (da) 1997-09-29
IE911844A1 (en) 1991-12-04
IS3710A7 (is) 1991-12-02
CN1326782A (zh) 2001-12-19
IL98273A0 (en) 1992-06-21
LV10292B (en) 1995-08-20
IS1751B (is) 2000-07-21
KR100212411B1 (en) 1999-08-02
DE69125489T2 (de) 1997-08-14
UA39165C2 (uk) 2001-06-15
ES2099159T3 (es) 1997-05-16
JO1694B1 (en) 1992-08-09
EP0535048A1 (en) 1993-04-07
DZ1503A1 (fr) 2004-09-13
ZA913778B (en) 1992-02-26
YU49138B (sh) 2004-03-12
FI114639B (fi) 2004-11-30
AP207A (en) 1992-08-18
SE9001985D0 (sv) 1990-06-01
IL98273A (en) 2005-11-20
NO924528L (no) 1992-11-24
PT97836B (pt) 1998-11-30

Similar Documents

Publication Publication Date Title
PH30761A (en) An infant formulation fortified with bile salt-activated lipase.
WO1998014592A3 (en) Telomerase reverse transcriptase
CA2144312A1 (en) Unsaturated aliphatic dicarboxylic acids
AU2738497A (en) Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder
CA2278028A1 (en) Methods for improving transformation efficiency
CA2137378A1 (en) D-enzyme compositions and methods of their use
ES543443A0 (es) Un metodo para la produccion de un preparado cosmetico a base de un diester de dioles y acidos dioicos c4-10.
CY1105398T1 (el) 5΄ ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ
AU2670495A (en) Ifn-beta liquid formulations
CA2306628A1 (en) Cosmetic formulations for the prevention and therapy of hair loss
EP0293766A3 (en) Emulsified compositions
IT8847640A0 (it) Dispositivo per la conservazione prolungata di prodotti al riparo dall'ossigeno dell'aria
EP1591528A3 (en) Method and compositions for delivery and expression of interferon-alpha nucleic acids
EP0919621A4 (en) TAK1 HUMAN AND DNA ENCODING IT
CA2108358A1 (en) Gene expression in bacilli
EP0317279A3 (en) Peptides for use in the purification of factor viii
CA2216004A1 (en) Improved rinse aid compositions containing phosphate esters
Gharavi Molecular cloning of the human lipoxygenase gene
WO2001012663A3 (en) Hematopoietic regulatory factors and methods of use thereof
Arnold Serine-lactones in syntheses of amino acids
WO2001036458A3 (en) Drosophila ced-6 homologue
IT8820978A0 (it) Composizione erbicida conselettivita' aumentata e processo per la preparazione di entrambi i componenti ingredienti attivi in un solo stadio.
IT1216383B (it) Metodo per adornare oggetti metallici,in particolare oggetti decorativi per arte funeraria o per la casa, e oggetti cosi'ottenuti
WO2002006328A3 (en) Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
RU99114027A (ru) Нуклеиново-кислотные и аминокислотные последовательности helicobacter pylory и их вакцинные композиции